📋1. OVERVIEW & PROTOCOL

• Wolverine Blend Formulation: This 20mg research-grade combo synthesizes BPC-157 and TB-500 together for precise peptide signaling and controlled cellular response laboratory studies.
• Biological Focus: Developed for clinical assay models investigating simultaneous molecular interaction kinetics, cell-motility frameworks, and pathway-specific regulatory processes.
• Cellular Intensity: In-vitro testing tracks targeted structural protein organization networks, actin sequestration profiling, and combined tissue-remodeling signaling cascades.

🧪2. CHEMICAL PROPERTIES

• Molecular Profiles: Formulated with a sequence-verified blend combining BPC-157 (C62H98N16O22) and TB-500 (C38H68N10O14 active domain segment).
• Molar Mass Specifications: BPC-157 calibrated at 1419.55 g/mol and TB-500 structured at 889.02 g/mol.
• CAS Numbers Reference: 137525-51-0 (BPC-157) | 88534-08-9 (TB-500)
• Amino Acid Core Sequence: BPC-157 consists of 15 residues (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) and TB-500 contains 7 residues (Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln-OH).
• Reconstitution Protocol: Lyophilized freeze-dried white powder format; highly soluble in bacteriostatic water solvent systems under aseptic laboratory environments.
• Storage Protocol: Store the solid lyophilized material at -20°C thoroughly protected from light, moisture, and temperature cycling. Refrigerate reconstituted laboratory solutions at 2-8°C.

🔬3. AUDITED RESEARCH & SPECIFICATIONS

• Stability Advantage: Meticisously co-formulated to reduce reconstitution complexity in multi-peptide study designs, preserving the individual pharmacological profile of each molecular identity.
• Signaling Pathways: Main research targets analyze targeted actin polymerization dynamics, structural cytoskeletal binding sites, and tissue-remodeling cascades.
• Regulatory Safety Notice: This product is a reference reagent provided strictly for scientific investigation and laboratory use only. It is not approved by the FDA for human or therapeutic consumption.